HMGB1 ANTAGONIST Application WO-2020227603-A1 World Intellectual Property Organisation (WIPO) 12 Nov 2020
Treatment of myelodysplastic syndromes with 2-O and,or 3-O desulfated heparinoids Grant US-10052346-B2 United States of America 21 Aug 2018